Gemcitabine recalls

The FDA has published 6 recalls involving Gemcitabine since 2014. The latest was reported on 8 Jul 2026. Most were for particulate matter. Mylan Institutional has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls6since 2014
Last 12 months1reported
Class I350% of total
Ongoing1latest 8 Jul 2026

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 3 50%Class II 3 50%Class III 0 0%

By year

Ongoing gemcitabine recalls

1 active
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIGemcitabine Injection per (38 mg/mL) Single-Dose Vial recalledGemcitabineMcKessonTemperature AbuseNationwide

All gemcitabine recalls, newest first

6 total

Should you stop taking Gemcitabine?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.